Pfizer Inc.

NYSE:PFE  
50.10
+1.81 (+3.75%)
5:00:27 PM EDT: $50.00 -0.10 (-0.20%)
Positive Earnings Pre-Announcement

Pfizer Reports Q2 EPS Of $1.73

Published: 07/28/2022 10:59 GMT
Pfizer Inc. (PFE) - Pfizer Reports Second-quarter 2022 Results.
Q2 Earnings per Share $1.73.
Second-quarter 2022 Revenues of $27.7 Billion, Reflecting 53% Operational Growth.
Raises Full-year 2022 Financial Guidance for Revenues and Adjusted Diluted Eps(3) by $2 Billion and $0.24, Respectively.
Second-quarter 2022 Adjusted Diluted EPS of $2.04.
Including Foreign Exchange Impacts, Pfizer Reaffirms 2022 Revenue Guidance of $98.0 to $102.0 Billion.
Raises Lower End of 2022 Adjusted Diluted EPS Guidance by $0.05 to a Range of $6.30 to $6.45.
Current Financial Guidance Does Not Anticipate Any Additional Share Repurchases in 2022.
Sees 2022 Revenues $98.0 Billion to $102.0 Billion.
Sees 2022 Adjusted Diluted EPS $6.30 to $6.45.
Paxlovid Contributed $8.1 Billion in Global Sales in Quarter.
Qtrly Comirnaty Sales Globally, Up 20% Operationally.
Q2 Earnings per Share View $1.78, Revenue View $25.74 Billion -- Refinitiv Ibes Data (analyst estimates).
Reaffirms 2022 Revenue Guidance for Comirnaty and Paxlovid of About $32 Billion and About $22 Billion, Respectively.
FY2022 Earnings per Share View $6.59, Revenue View $102.92 Billion -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $22.01 Billion
Adjusted EPS is expected to be $1.50

Next Quarter Revenue Guidance is expected to be $24.66 Billion
Next Quarter EPS Guidance is expected to be $1.37

More details on our Analysts Page.